Literature DB >> 34269987

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection.

Haripal Kashyap1, R N Seshendra Kumar2, Srishti Gautam1, Arvind Gupta1, Swati Gupta1, Prashant K Tiwari1.   

Abstract

Entities:  

Year:  2021        PMID: 34269987      PMCID: PMC8284036          DOI: 10.1007/s12098-021-03832-3

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
To the Editor: Multisystem inflammatory syndrome–children (MIS-C) is a newly recognized spectrum of disease manifestations in children associated with COVID-19 infection [1]. This letter aims to describe the clinicotherapeutic profile of MIS-C COVID-19 cases admitted at a tertiary hospital in Delhi-NCR. We observed 12 cases with a median age of 6.5 y (9 male; 3 female). Eleven showed seropositivity for COVID-19 while 1 had a positive COVID-19 RT-PCR. As proposed by Gupta et al. [2], cases were divided into 3 groups: febrile inflammatory state (5 cases), Kawasaki-like illness (3 cases), and toxic shock syndrome-like classical MIS-C (4 cases). Fever was present in all cases. Gastrointestinal system was the most commonly affected system with vomiting being the most common symptom. Cardiovascular symptoms were seen in 6 (50%) cases. Three children showed neurological impairment with 1 case each of refractory status epilepticus, acute disseminated encephalomyelitis (ADEM), and necrotizing encephalopathy. Respiratory system was involved in 5 (41.6%) children. Elevated CRP was noted in all children, elevated ferritin in 8 (66.7%), elevated D-dimer in 10 (83.3%), and deranged PT/INR/aPTT in 4 (33%) cases. High Pro-BNP was seen in 8; of which, 4 showed deranged ejection fraction. Consolidation and/or pleural effusion was seen in 7 (58.3%) cases. All children received steroids, while 7 children received IVIg. LMWH and aspirin were given to children with raised D-dimer and Kawasaki-like illness, respectively. Six children needed vasopressor support. Three patients died during the course of the disease while 1 suffered morbidity in the form of hemiparesis. Rest all were discharged after full recovery of presenting symptoms. MIS-C COVID-19 should be considered in cases with longstanding fever and/or multisystem involvement. In the absence of standardized guidelines, clinicians are often missing mild cases or misdiagnosing the presentation [3]. It also emphasizes the need for further studies in this field.
  1 in total

1.  Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.

Authors:  Michael Levin
Journal:  N Engl J Med       Date:  2020-06-29       Impact factor: 91.245

  1 in total
  2 in total

1.  Multisystem inflammatory syndrome in children (MIS-C) showing disseminated aspergillosis, cytomegalovirus reactivation and persistent SARS-COV-2: Case report with autopsy review.

Authors:  Mana Taweevisit; Ariya Chindamporn; Kritsaporn Sujjavorakul; Rujipat Samransamruajkit; Paul Scott Thorner
Journal:  Pathol Res Pract       Date:  2022-09-05       Impact factor: 3.309

Review 2.  Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes.

Authors:  Mônica O Santos; Lucas C Gonçalves; Paulo A N Silva; André L E Moreira; Célia R M Ito; Fernanda A O Peixoto; Isabela J Wastowski; Lilian C Carneiro; Melissa A G Avelino
Journal:  J Pediatr (Rio J)       Date:  2021-12-03       Impact factor: 2.990

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.